THROMBONEX20-TABLETS | Invision
WORLD CLASS HEALTHCARE SOLUTIONS
Call: 080-40987695,96,97
Toll Free: 1-800-108-5011
Contact Us
shadow

Anticoagulant

Home »  Products » Anticoagulant  » Thrombonex-20 Tablets
pro-details

Thrombonex 20 Tablets

Rivaroxaban 20 Mg

Dosage

Nonvalvular atrial fibrillation

To reduce risk of stroke 20Mg PO qday.

Reduction of risk of CV events 2.5 Mg PO BID plus aspirin.

Indications

Reduction of-

Risk of stroke and systemic enbolism in nonvalvular atrial fibrillation

Risk of recurrence of deep vein thrombosis & pulmonary embolism

Risk of major cardiovascular events in patients with chronic coronary artery diseas (CAD) or peripheral artery disease (PAD)

Prophylaxis of deep vein thrombosis following hip or knee replacement surgery

Deep vein thrombosis

Pulmonary embolism

 

A new way to present thrombosis an oral direct factor Xa inhibitor that doesn't require routine coagulation monitoring. 

A direct oral anticoagulant approved for the prevention of stroke and systemic embolism in patients with non valvular atrial fibrillation.

in a study involving 8000 patients with DVT and pilmonary embolism, Rivaroxaban shown to be as effective as subcutaneous enoxaparin sodium.

Rivaroxaban is superior to warfarin and similar to dabigatran, apixaban and edoxaban for the prevention of stroke or embolism.

An effective therapy to prevent venous thromboembolism fibrillating total hip or knee replacement surgeries.

Compassable to warfarin in efficacy and safely energy mrbidly obese patients with atrial fibrillation.